Receptor-Mediated Endocytosis of α-Galactosidase A in Human Podocytes in Fabry Disease-Reference-Cited by-同舟云学术

Receptor-Mediated Endocytosis of α-Galactosidase A in Human Podocytes in Fabry Disease

Published:2011-09-19 Issue:9 Volume:6 Page:e25065
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Prabakaran Thaneas,Nielsen Rikke,Larsen Jakob V.,Sørensen Søren S.,Rasmussen Ulla Feldt-,Saleem Moin A.,Petersen Claus M.,Verroust Pierre J.,Christensen Erik I.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference68 articles.

1. Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency.;RO Brady;N Engl J Med,1967

2. Fabry's disease: alpha-galactosidase deficiency.;JA Kint;Science,1970

3. α-Galactosidase A deficiency: Fabry disease.;RJ Desnick,2006

4. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey.;A Mehta;Eur J Clin Invest,2004

5. The renal lesion in angiokeratoma corporis diffusum.;JR Colley;Br Med J,1958

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanotechnology-Based Drug Delivery Systems for Treating Acute Kidney Injury;ACS Biomaterials Science & Engineering;2024-09-03

2. Comparative study on incorporation of three recombinant human α-galactosidase A drugs (agalsidases) into cultured fibroblasts and organs/tissues of Fabry mice;Molecular Genetics and Metabolism Reports;2024-09

3. The fate of immune complexes in membranous nephropathy;Frontiers in Immunology;2024-08-08

4. Antibrush Border Antibody Disease: A Case Series;Kidney Medicine;2024-07

5. Identification of a novel nonsense mutation in α-galactosidase A that causes Fabry disease in a Chinese family;Renal Failure;2024-06-07